¶ DynPort Vaccine Company
.png)
DynPort Vaccine Company LLC (DVC) is an American biotechnology company based in Frederick, Maryland. It is “dedicated to the development and licensure of safe and efficacious biodefense vaccines.”
¶ History
DynPort was founded in 1997 as a joint venture between defense contractor DynCorp and Porton International, a wholly-owned subsidiary of Ipsen.[1][2] That year, the United States Department of Defense (DoD), through its Joint Vaccine Acquisition Program (JVAP), contracted DynPort to manufacture 300,000 doses of a new smallpox vaccine for the military.[3] The company began working on the project in 1998.
Dr. Robert Malone joined the company as Associate Director of Clinical Research in 2002, leaving the position in 2003.[4]
On March 30, 2004, Commonwealth Biotechnologies announced it had entered a partnership with DynPort through which the companies would “co-venture wherever appropriate to compete for new biodefense vaccine development funding.”[2:1]
¶ Organization
| Name | Position | Notes |
|---|---|---|
| Terry Irgens | President (former) | Logicon, Defense Personnel Support Center, Naval Medical Logistics Command (NMLC) |
| Michael Langford | Senior Vice President & Chief Scientific Officer (former)[5] | United States Army, United States Army Acquisition Corps |
| Robert Malone | Associate Director of Clinical Research (former) | Worked on DynPort's smallpox vaccine |
¶ Products
DynPort developed vaccines and related biologicals for a number of diseases including:[6]
- Anthrax vaccine
- Botulinum multivalent vaccine
- Plague vaccine
- Smallpox vaccine
- Tularemia vaccine
- Vaccinia immune globulin
- Venezuelan equine encephalitis (VEE) vaccine
¶ External links
¶ Further reading
- April 9, 2020: "A Killer Enterprise: How One of Big Pharma’s Most Corrupt Companies Plans to Corner the Covid-19 Cure Market" by Whitney Webb, published by The Last American Vagabond
Hogan, B. (January/February 2002). A Biodefense Boondoggle. Mother Jones. https://web.archive.org/web/20051129154849/http://www.motherjones.com//news/outfront/2002/01/biodefense.html ↩︎
Harris, R. B. (2004, March 30). Commonwealth Biotechnologies, Inc. Launches New Biodefense Business Initiative. Securities and Exchange Commission. http://archive.today/2023.03.20-195208/https://www.sec.gov/Archives/edgar/data/1042418/000119312504053263/dex991.htm ↩︎ ↩︎
Cohen, J., & Marshall, E. (2001, October 19). Vaccines for Defense: A System in Distress. UCLA Department of Epidemiology. http://archive.today/2021.12.13-221406/http://www.ph.ucla.edu/epi/bioter/vaccinesfordefense.html ↩︎
Malone, R. W. (2017, March). RWM CV. Squarespace. https://web.archive.org/web/20230119104151/https://static1.squarespace.com/static/550b0ac4e4b0c16cdea1b084/t/58e5406b5016e1f1acacae75/1491419246742/RWM+CV+March+2017.pdf ↩︎
Leadership. DynPort. Retrieved December 8, 2002, from https://web.archive.org/web/20021208085639/http://www.dynport.com/leadership.htm ↩︎
Products. DynPort. Retrieved December 8, 2002, from https://web.archive.org/web/20021208091702/http://www.dynport.com/products.htm ↩︎